NCT01273324

Brief Summary

The dual mobility design concept for acetabular liners, as is used in the Restoration ADM Acetabular System, has been applied in various implants since its introduction by Gilles Bousquet in France in 1976. Dual mobility cups have shown good clinical results and have been particularly lauded for low incidence of dislocations. However, the wear performance of this design concept has not been proven to date. As wear particles are a possible contributing factor in aseptic loosening, the assessment of wear and fixation is an important step in proving this implant design. The proposed study will combine RSA and peri-prosthetic bone mineral density as well as outcome questionnaires to provide a complete in vivo evaluation of prosthesis fixation, polyethylene wear, and objective and subjective outcomes for the Restoration ADM Acetabular System.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 7, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 10, 2011

Completed
10 months until next milestone

Study Start

First participant enrolled

November 1, 2011

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
3.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

August 19, 2021

Status Verified

August 1, 2021

Enrollment Period

4.7 years

First QC Date

January 7, 2011

Last Update Submit

August 18, 2021

Conditions

Keywords

Osteoarthritis

Outcome Measures

Primary Outcomes (1)

  • RSA migration

    3 years

Secondary Outcomes (2)

  • RSA wear

    3 years

  • Questionnaires

    3 years

Study Arms (1)

ADM

ADM Cup

Device: ADM Cup

Interventions

ADM CupDEVICE

ADM Cup

Also known as: Styrker ADM Acetabular Cup
ADM

Eligibility Criteria

Age21 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Osteoarthritis of the hip

You may qualify if:

  • Symptomatic osteoarthritis of the hip indicating primary total hip arthroplasty
  • Between the ages of 21 and 80 inclusive
  • Patients willing and able to comply with follow-up requirements and self-evaluations
  • Ability to give informed consent

You may not qualify if:

  • Inflammatory arthritis
  • BMI \>40
  • Post-traumatic arthritis of the hip
  • Prior arthroplasty with the affected hip
  • Hip dysplasia
  • Active or prior infection
  • Medical condition precluding major surgery
  • Severe osteoporosis or osteopenia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Capital District Health Authority

Halifax, Nova Scotia, B3H 3A7, Canada

Location

MeSH Terms

Conditions

Osteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Michael Dunbar, MD, FRCSC, PhD

    Dalhousie University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

January 7, 2011

First Posted

January 10, 2011

Study Start

November 1, 2011

Primary Completion

July 1, 2016

Study Completion

December 1, 2019

Last Updated

August 19, 2021

Record last verified: 2021-08

Locations